The Latest Regenerative Medicine Articles from Streetwise Reports
Research Report This French developer of investigative cancer therapies is focused on advanced its remaining programs and is amply funded to do so, noted an Oppenheimer report.
Research Report Disease response and survival rates are impressive in updated results from several studies, noted an H.C. Wainwright & Co. report.
Research Report One year out, overall efficacy was 93% in the patients treated with a new autologous immunotherapy, noted a ROTH Capital Partners report.
Showing Results: 1 to 3 of 3